AbbVie Inc (ABBV) Raises Dividend to $0.96 Per Share

Adjust Comment Print

Princeton Portfolio Strategies Group Llc who had been investing in Abbvie Inc for a number of months, seems to be less bullish one the $187.35B market cap company. The firm attains analyst recommendation of 2.40 on scale of 1-5 with week's performance of -0.48%. About 14.63M shares traded or 54.18% up from the average.

Kiwi Wealth Investments Limited Partnership increased its holdings in shares of AbbVie Inc (NYSE:ABBV) by 10.3% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. It has underperformed by 33.21% the S&P500. (EGHT) by 273.42% based on its latest 2017Q3 regulatory filing with the SEC. Eaton Vance Management acquired 385,198 shares as Abbvie Inc (ABBV)'s stock rose 6.17%. The institutional investor held 97,266 shares of the major banks company at the end of 2017Q3, valued at $1.67 million, down from 129,575 at the end of the previous reported quarter. In terms of the mechanics underlying that movement, traders will want to note that the stock is trading on a float of 1.10% with $1.59 Billion sitting short, betting on future declines. (CEM) has risen 5.19% since February 15, 2017 and is uptrending. It has underperformed by 4.69% the S&P500.

Among 13 analysts covering 8×8 (NASDAQ:EGHT), 8 have Buy rating, 0 Sell and 5 Hold. Therefore 50% are positive. The firm has "Outperform" rating given on Thursday, November 10 by Keefe Bruyette & Woods. The firm earned "Neutral" rating on Thursday, September 8 by JP Morgan. BMO Capital Markets downgraded the stock to "Market Perform" rating in Friday, June 10 report. The company operates in the Healthcare sector with a market capitalization of 183.5 Million. The stock of The Southern Company (NYSE:SO) has "Hold" rating given on Tuesday, January 16 by SunTrust. Finally, Evercore ISI reiterated a "buy" rating and set a $144.00 price target on shares of AbbVie in a report on Monday, January 29th.

Next Financial Group Inc, which manages about $1.77 billion and $359.28 million US Long portfolio, upped its stake in Spdr Gold Trust (GLD) by 4,825 shares to 20,670 shares, valued at $2.56 million in 2017Q3, according to the filing. It also increased its holding in Ishares Tr (SHY) by 7,800 shares in the quarter, for a total of 53,900 shares, and has risen its stake in Amgen Inc (NASDAQ:AMGN). BP p.l.c. (NYSE:BP) has risen 15.51% since February 16, 2017 and is uptrending. Therefore 32% are positive. (NYSE:ABBV) on Wednesday, October 11 to "Outperform" rating. Jefferies maintained the shares of ABBV in report on Friday, January 26 with "Buy" rating.

Teachers' groups reject President Trump's suggestion to arm educators
He said Attorney General Jeff Sessions is "very much after that" as well as gangs. "We'll solve it together", Trump said. Trump said the discussion was focused on security measures at campuses and addressing mental health issues.


In other AbbVie news, insider Laura J. Schumacher sold 145,510 shares of the business's stock in a transaction that occurred on Friday, December 15th. The stock of Target Corporation (NYSE:TGT) earned "Buy" rating by Citigroup on Thursday, May 19. The rating was upgraded by Morgan Stanley to "Overweight" on Monday, November 2. The company was maintained on Friday, February 2 by Argus Research. The firm earned "Buy" rating on Tuesday, December 5 by Leerink Swann. (NASDAQ:CSCO), 26 have Buy rating, 0 Sell and 12 Hold. The rating was maintained by Jefferies with "Buy" on Tuesday, January 16. Perhaps, that suggests something about why 0.08% of the outstanding share supply is held by institutional investors. The company reported $1.42 EPS for the quarter, beating analysts' consensus estimates of $1.40 by $0.02. It dived, as 55 investors sold AbbVie Inc. shares while 640 reduced holdings. Hudock Capital Group LLC raised its position in AbbVie by 109.5% in the second quarter. Wunderlich Managemnt holds 23,679 shares or 1.57% of its portfolio. Moreover, Eaton Vance Management has 0.71% invested in AbbVie Inc. Vigilant Cap Llc accumulated 1,000 shares or 0% of the stock. In the last quarter, insiders sold 450,743 shares of company stock worth $43,153,684. Moreover, Pinnacle Associates Limited has 0.27% invested in AbbVie Inc. Andra Ap, a Alabama-based fund reported 35,100 shares. Abbvie Inc now has $189.99B valuation. We have $129.34 PT which if reached, will make NYSE:ABBV worth $17.05 billion more. Sterling Capital Mngmt Limited Co invested in 1.18% or 1.41M shares.

AbbVie Inc. (NYSE:ABBV) gross margin percentage stands at 76.5% while its operating margin for the past trailing twelve month is 36 percent and its overall profit margin (ttm) is 24.1 Percent. (NYSE:ABBV). Daiwa Sb has invested 0.02% in AbbVie Inc. (NYSE:ABBV). Aureus Asset Mgmt Llc holds 0.05% or 3,494 shares. Findit, Inc. (OTCMKTS:FDIT) has 0.00% since February 16, 2017 and is. (NYSE:ABBV). Mason Street Advsr Lc holds 221,290 shares. Acropolis Investment Management LLC bought a new stake in shares of AbbVie during the 2nd quarter worth $106,000. It also reduced its holding in Goldman Sachs Bdc Inc Shs (NYSE:GS) by 88,793 shares in the quarter, leaving it with 63,724 shares, and cut its stake in Facebook Inc Com Usd0.000006 Cl A (NASDAQ:FB).

Since September 11, 2017, it had 0 buys, and 5 selling transactions for $25.59 million activity. On Thursday, September 28 the insider Michael Robert A. sold $589,512. About 3.57 million shares traded. (NASDAQ:CSCO) shares. On Monday, September 11 BHATT PRAT sold $821,900 worth of Cisco Systems, Inc. Finally, Garde Capital Inc. bought a new position in AbbVie during the second quarter worth $325,000.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Comments